Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Mira G. P. Zuidgeest"'
Autor:
Julia Kopanz, Bart Lagerwaard, Magdalena Beran, Jorien Veldwijk, Julia K. Mader, Tina Pöttler, Dietrich Tews, Diederick E. Grobbee, Mira G. P. Zuidgeest
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 11, Pp n/a-n/a (2024)
Abstract Decentralized clinical trials (DCTs), in which all or part of the trial activities are moved to the participants' immediate surroundings, promise to improve trial conduct. However, no evidence is available on what motivates people to partici
Externí odkaz:
https://doaj.org/article/0180adef2af0498e8648e17eeabe1dfd
Autor:
Arnela Suman, Jasmijn van Es, Helga Gardarsdottir, Diederick E. Grobbee, Kimberly Hawkins, Megan A. Heath, Isla S. Mackenzie, Ghislaine van Thiel, Mira G. P. Zuidgeest
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-12 (2022)
Abstract Background The COVID-19 pandemic significantly impacted the conduct of clinical trials through delay, interruption or cancellation. Decentralised methods in clinical trials could help to continue trials during a pandemic. This paper presents
Externí odkaz:
https://doaj.org/article/238be541e71748bfa671285e9c2512d0
Autor:
Sophie H. Bots, Mira G. P. Zuidgeest, Aisha Gohar, Anouk L. M. Eikendal, Alessandra Petrelli, Harmieke van Os-Medendorp, Marieke F. van der Schaaf, Nina M. van Sorge, Myriam van Wijk, Sabine Middendorp, Caroline M. Speksnijder, Kerstin Klipstein-Grobusch, Vicky Seyfert-Margolis, Esther Mollema, Femke van Wijk, Hester M. den Ruijter
Publikováno v:
Frontiers in Medicine, Vol 5 (2018)
Despite the recent movements for female equality and empowerment, few women occupy top positions in scientific decision-making. The challenges women face during their career may arise from societal biases and the current scientific culture. We discus
Externí odkaz:
https://doaj.org/article/98361f7b5ff14a7f85b8709b23a7e456
Autor:
Anthonius de Boer, Helga Gardarsdottir, Amos J de Jong, Renske J Grupstra, Yared Santa-Ana-Tellez, Mira G P Zuidgeest
Publikováno v:
BMJ Open, Vol 12, Iss 8 (2022)
Objectives Decentralised clinical trial activities—such as participant recruitment via social media, data collection through wearables and direct-to-participant investigational medicinal product (IMP) supply—have the potential to change the way c
Externí odkaz:
https://doaj.org/article/43ef640d1ba24a48b2dd86bce3b1c53a
Autor:
Daniel, Boateng, Thomas, Kumke, Robin, Vernooij, Iris, Goetz, Anna-Katharina, Meinecke, Charlotte, Steenhuis, Diederick, Grobbee, Mira G P, Zuidgeest
Publikováno v:
Contemporary Clinical Trials. 125:107054
The GetReal Trial Tool is a decision support tool to assess the impact of design choices on generalizability of clinical trials to routine clinical practice, while taking into account the risk of bias, precision, acceptability and operational feasibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0123fdb7cdeda0423dfb14645fd6a7c
https://doi.org/10.1016/j.cct.2022.107054
https://doi.org/10.1016/j.cct.2022.107054
Autor:
Arnela, Suman, Jasmijn, van Es, Helga, Gardarsdottir, Diederick E, Grobbee, Kimberly, Hawkins, Megan A, Heath, Isla S, Mackenzie, Ghislaine, van Thiel, Mira G P, Zuidgeest
Publikováno v:
TrialsReferences. 23(1)
The COVID-19 pandemic significantly impacted the conduct of clinical trials through delay, interruption or cancellation. Decentralised methods in clinical trials could help to continue trials during a pandemic. This paper presents the results of an e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4935714ea9027e204b1dbde23a10173a
https://pubmed.ncbi.nlm.nih.gov/36203202
https://pubmed.ncbi.nlm.nih.gov/36203202
Autor:
Ghislaine José Madeleine Wilhelmien van Thiel, Amos Jochanan de Jong, Mira G. P. Zuidgeest, Dinesh Mistry, Yared Santa-Ana-Tellez, Satu Johanna Siiskonen, Anthonius de Boer, Helga Gardarsdottir
Publikováno v:
Clinical Pharmacology & Therapeutics
Clinical Pharmacology and Therapeutics
Clinical Pharmacology & Therapeutics, 109(6), 1517. Wiley
Clinical Pharmacology and Therapeutics
Clinical Pharmacology & Therapeutics, 109(6), 1517. Wiley
The coronavirus disease 2019 (COVID-19) pandemic and the accompanying control measures have significantly affected clinical trial (CT) conduct, and sponsors have needed to make rapid changes to their CT operations. As a result, regulatory guidance wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d5fa79ecfc68b446644e51246c94b4e
https://hdl.handle.net/1874/406881
https://hdl.handle.net/1874/406881
Autor:
Anna Katharina Meinecke, Mira G. P. Zuidgeest, Paco M J Welsing, George Kafatos, Gaëlle Nachbaur, Des Burke, Maria Kubin, Sven Trelle, Matthias Egger
Publikováno v:
Journal of Clinical Epidemiology. 91:13-22
Pragmatic trials can improve our understanding of how treatments will perform in routine practice. In a series of eight papers, the GetReal Consortium has evaluated the challenges in designing and conducting pragmatic trials and their specific method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbf57114df50996c15cbb615dc92147e
https://doi.org/10.1016/j.jclinepi.2017.07.003
https://doi.org/10.1016/j.jclinepi.2017.07.003
Autor:
Ghislaine J. M. W. van Thiel, Mira G. P. Zuidgeest, Johannes J. M. van Delden, Iris Goetz, Rieke van der Graaf, Shona Kalkman, Diederick E. Grobbee
Publikováno v:
Bioethics. 31:136-143
Pragmatic trials aim to directly inform health care decision-making through the collection of so-called 'real world data' from observations of comparative treatment effects in clinical practice. In order to ensure the applicability and feasibility of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::565a72eef3a56fbd3fc11319a1a14e37
https://doi.org/10.1111/bioe.12315
https://doi.org/10.1111/bioe.12315
Autor:
Ghislaine J. M. W. van Thiel, Mira G. P. Zuidgeest, Diederick E. Grobbee, Rolf H.H. Groenwold, Elaine A. Irving, Iris Goetz
Publikováno v:
Journal of Clinical Epidemiology, 88, 7. Elsevier USA
This is the introductory paper in a series of eight papers. In this series, we integrate the theoretical design options with the practice of conducting pragmatic trials. For most new market-approved treatments, the clinical evidence is insufficient t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69e235d2b57b5f3b2063c34e700c902f
https://dspace.library.uu.nl/handle/1874/357119
https://dspace.library.uu.nl/handle/1874/357119
